The presentation shows the Market understanding of healthcare industry in a few cities. This tells what could be done with the information about tests, hospitals, doctors present in a city. it basically focuses on increasing the transparency between producers and consumers in this industry.
Market understanding of healthcare industry in 1 tier cities of india
1. Training Report
On
“ Market Understanding of Healthcare Industry in 1
Tier Cities of India”
From
Nirvair Online Solutions Pvt. Ltd., Gurgaon
Submitted by:
Submitted to:
Anjana, Priya, Naman, Deepak Ambala College of Engg. & Applied
Research
2312402,2312404,2312410,2312411 Dept. of Biotechnology
2. Objective
To collect the statistical data about current status
of Healthcare Industry in India
To brainstorm its applications
To create awareness about medical services and
common diseases.
To further improve the current status of this
industry
3. Contents
Medical Tourism
Ayurveda
Pharmaceuticals in India
Research and Development
Labour Force
Recommendations
Scientific Understanding of
Medical Tests
Brief Overview on Indian
HealthCare System
Scientific understanding of
diseases
Indian healthcare
infrastructure
Telemedicine
Health Insurance Market
(India)
Nutraceuticals Market
4. Brief Overview
The Healthcare Sector comprises of
Hospitals
Diagnostics
Pathology
Equipment and Supplies
Medical Tourism
Telemedicine, etc
It is one the prominent contributors to India’s GDP.
It attracts large number of domestic as well as international players
India has become an attractive destination for
Medical Tourism
Clinical Studies
Research and Development Programs
5. List of Hospitals in NCRs
Total 168 hospitals
studied in NCRs.
These regions
included:
Delhi, Faridabad,
Ghaziabad, Noida,
Greater Noida,
Gurgaon
6.
7. Diagnostic Tests
Studied about 150 diagnostic
centers in about 15 cities
Compared the availability of
various diagnostic tests and
compared their costs
This creates awareness about
every aspect like cost differences
and quality of services.
9. Some Facts
The HealthCare Industry is presently worth $50
billion.
Second largest service sector employer in the
country.
Provides jobs for 4.5 million people directly or
indirectly.
Some studies estimate doubling of size of the
sector to $100 billion by the end of 2015
10. Growth of Indian Healthcare
Industry
A sudden paradigm shift in the last five years.
This shift has become visible only in the last two
years.
A shift from an unorganized to an organized
structure.
Apollo started the trend of corporate hospitals in
India.
11. Factors for the HealthCare growth
in India
Strong Indian Economy
Increasing options for Healthcare Financing
Increasing Opportunities in Healthcare
delivery
Better Profitability
Medical Tourism
Increasing demand from within the county
13. Top Health Care Hospitals and
Diagnostic Centres
ALL INDIA INSTITUTE OFMEDICAL SCIENCES
APOLLO HOSPITAL
NATIONAL INSTITUTE OF MENTAL HEALTH AND
NEUROSCIENCES
WIPRO GE HEALTHCARE
POST GRADUATE INSTITUTE OF MEDICAL SCIENCES &
RESEARCH
TATA MEMORIAL HOSPITAL
LILAWATI HOSPITAL & RESEARCH CENTRE
FORTIS HEALTHCARE LTD.
BOMBAY HOSPITAL
14. Some Very Common Diseases
Brain Tumour: A benign or malignant growth in the brain.
Symptoms: Headache, Nausea, Seizures, Fatigue, Personality
changes
TYPES :-
1. Meningioma
2. Lymphoma
3. Acoustic Neuroma
4. Medulloblastoma
TREATMENT METHODS:
Surgery-Radiotherapy-Chemotherapy-Targeted therapy-Tumor Treating Fields
15. Melanoma
(Malignant Melanoma)
Type of cancer that develops from the pigment-containing cells
known as melanocytes.
Types of Melanoma
1.Superficial spreading melanoma
2.Nodular melanoma
3.Lentigo maligna melanoma
4.Acral lentiginous melanoma
5.Amelanotic melanoma
Treatments
1.Surgery
2.Radiotherapy for melanoma
3.Chemotherapy for melanoma
16. Sarcoma
A cancer that arises from transformed cells of
mesenchymal origin .
TYPES
Soft tissue sarcoma
Bone sarcoma
TREATMENT
Surgery
Radiotherapy
17. HODGKIN’S LYMPHOMA
Type of lymphoma, a cancer that starts in white blood cells
(lymphocytes).
TYPES
Classical Types
Nodular lymphocyte predominant type
TREATMENT
Chemotherapy
Radiotherapy
Steroid medication
18. Indian Healthcare
Infrastructure
As on December 2014, about 335 medical colleges were
recognized by the Indian Medical Council.
As on 2001, a total of 53,900 MBBS doctors were
registered.
The current doctor population ratio - 1:1800.
At present approximately 50000 doctors are being
produced annually in the nation, but the number needs to
go up.
19. By 2020, the Indian healthcare industry is estimated to be worth
US$ 275.6 billion.
Currently, 8 per cent of India’s GDP.
Requirement : US$ 80 billion more in the next five years to meet
targets
(According to Mr Pradipta K Mohapatra, Chairman, Executive &
Business Coaching Foundation India Ltd and Past Chairman,
Confederation of Indian Industry (CII), Southern Region. )
20. Survey Analysis on Infrastructure
51% of the surveyed population believes that there is
considerable difference between performances of
hospitals in their region.
39% : quality of govt. hospitals is bad
35% : Govt. hospitals are average.
18% : govt. hospitals are very bad.
Only 8% believes that quality of govt. hospitals are good.
21. 57% : Quality of private hospitals is good and
22% : Quality is just an average.
21% : Quality of private hospitals is very good.
83% : Cost of private hospital is quite expensive.
22. Measures Taken to Improve
Skill upgradation and recertification of Medical
practitioners every five years.
Upgradation of medical knowledge.
Setting up of Medical Grants Commission for funding
new Government Medical and Dental colleges.
Encouragement of all States to establish University of
Health Sciences (UHS).
23. Telemedicine
Telemedicine is the ability to provide
interactive healthcare utilizing modern
technology and telecommunications.
Various telemedicine usage models:
Store and Forward (asynchronous):
Home Health Telemedicine
Realtime
24. Recommendations
More medical colleges
Attract more FDI investment
Student exchange programmes
More special medical schemes
Branding Healthcare Industry
Preserve and promote Ayurvedic Medical System
Telemarketing and social marketing
Seminars and workshop (build awareness; stop corruption)
26. Need of Health Insurance
Government Hospitals: Inadequate facilities
Expensive Medicines: Diagnostic charges are
beyond common man’s reach.
High cost of Specialists.
Tax benefit under section 80 D of the Income Tax
Act
27. Standard Health Insurance: Features
Room and boarding expenses provided by the hospital
Nursing expenses
Diagnostic and medicine expenses
Other Services: Surgeon, Anesthetist, Medical
Practitioner, Consultants, Specialist fees, Anesthesia,
blood, oxygen, operation theatre expenses, cost of
surgical appliances, medicines and drugs and similar
expenses.
28. Companies Category
Non-Life Insurance:
Public: Companies like Oriental, National Insurance, United India, etc.
Private: Companies like ICICI Lombard, Reliance, Bajaj Allianz, etc.
• Specialized Health Insurance Companies:
Offers Core Health Insurance services & Products only.
Examples: Star Health & Allied Insurance, Apollo DKV Insurance
Life Insurance Companies:
Addresses following needs:
Saving
Pension
Retirement
Investment
Players are LIC and other private players
29. Target Customers
Working Class Individuals
Working Professionals with Family.
Students
Senior Citizens
Small and Medium Enterprises/ Corporate
Houses
35. MEDICAL TOURISM
INTRODUCTION
Travelling from less developed to more developed regions
for medical services
MEDICAL TOURISM IN INDIA
30% growth rate
9500 crores by 2015
Health capital of India
36. ADVANTAGES OF MEDICAL TOURISM IN
INDIA
Quality and experience of doctors and surgeons
Most doctors and nurses are fluent in English
Latest medical equipment
Low cost
37. COMPETITION
Thailand, Singapore, Malaysia and Philippines are
the major competitors
Thailand is more popular for cosmetic surgery.
In complex procedures Singapore has a
technology advantage.
Cost in Thailand is also less than Singapore
The Malaysian government is aggressively
promoting medical tourism.
40. AYURVEDA
INTRODUCTION
Increasing popularity in Western Countries
Availability of good infrastructure
HERBAL TOURISM IN KERALA
Kerala is becoming one of the major destination of herbal tourism
Kerala has an excellent network of hospitals
International standard of facilities
42. •The Indian pharmaceutical industry is the world's second-
largest by volume.
•India's bio-tech industry clocked a 17 percent growth with
revenues of Rs.137 billion ($3 billion) in the 2013-14 financial
year .
•Bio-Pharmaceutical was the biggest contributor generating 60
percent of the industry's growth at Rs. 8,829/- crore, followed
by bio-services at Rs.2,639/- crore and bio-agri at Rs.1,936
crore.
Pharmaceuticals in India
43. Pharmaceutical Facts
The first pharmaceutical company : Bengal
Chemicals and Pharmaceutical Works, formed
in Calcutta in 1903.
44. Purely Indian pharmaceutical companies is fairly
low.
Mainly operated, controlled by dominant foreign
companies having subsidiaries in India.
Most of the business is done by SMEs (Small &
Medium Enterprises).
45. Pharmaceutical companies operating in India, even the
multinationals, employ Indians at all levels.
Ownership usually passes from father to son & the founding
family holds a majority share.
Home grown pharmaceuticals, are often a mix of public &
private enterprise.
Globally, India currently holds a modest 1-2% share, growing at
around 10% per year.
There are 74 U.S. FDA-approved manufacturing facilities in India.
More than in any other country outside the U.S.A.
In 2005, almost 20% of all Abbreviated New Drug Applications
(ANDA) to the FDA were filed by Indian companies.
46. Top 10 Pharmaceutical Companies in India, as of
2014.
Rank Company Revenue 2014 (Rs crore) Revenue 2014 (Rs billion)
1 Sun Pharmaceuticals 4,198.96 41.989
2 Lupin Ltd. 4,162.25 41.622
3 Dr. Reddy's Laboratories 3,763.72 37.637
4 Cipla 2,463.59 24.635
5 Aurobindo Pharmaceutical 2,215.52 22.155
6 Cadila Healthcare 2,081.19 20.801
7 GlaxoSmithKline 1,773.41 17.734
8 Glenmark Pvt. Ltd. 1,613 16.13
9 Aventis Pharmaceutical 983.80 9.838
10 Ipca Laboratories 980.44 9.8044
47. Patents Act 1970 helped in encouraging the
industry and people in R & D.
Process patents were shortened to 5 to 7 years.
This act also made foreign countries lose interest
here & their place was taken by Indian Companies.
This increased their business both in India and
Government’s Role
48. Product development
Huge growth in past 20 years.
Firms have made their ways into the global market,
Both generic as well as patented products
Also taken stand to challenge various patents.
Another step: started Research & Development
Initial investment, but greater profits & recognition in the
long run.
49. Challenges
Inadequate regulation and large quantities of false drugs.
Global competitiveness
Underdeveloped new molecule discovery program.
Market leaders such as Ranbaxy spend only 5-10% of their
revenues on R&D.
This makes research equipment more expensive.
Lack of qualified scientists.
No connection between curriculum & the industry: Lack of
academic collaboration.
50. Research & Development
The Indian government has recognized the value of R&D
for the growth of their pharmaceutical businesses.
Tax deductions for expenses related to research &
development.
Granted other concessions, such as reduced interest rates
for export financing
Companies have access to IT industry that can partner
with them in R & D.